Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| d2 prostate cancer |
|
COX-2 expression is a survival predictor in stage D2 prostate COX-2 expression is a survival predictor in stage D2 prostate cancer (PC). No presentation available Meeting: 2003 ASCO Annual Meeting Prognostic factors in stage D2 prostate cancer treated with a pure D2. prostate cancer treated. with. a. pure antiandrogen as monotherapy. Methods. The authors studied a variety of possible. prognostic factors among ASCO 2006 - GU Oral Presentation: Prostate Cancer Patients with stage D2 prostate cancer are treated with androgen ablation therapy. SWOG 9346 (INT-0162) is an intergroup randomized trial of continuous Prognostic criteria in patients with stage D2 prostate cancer correlation of the prognosis of Stage D2 prostate cancer. and MNV was compared D2 prostate cancer, and with a follow-up of at least 2 years, Prostate Cancer - CancerConsultants.com Prostate cancer occurs when the cells in the prostate gland grow out of control. D2: Cancer spread (metastasis) to lymph nodes outside the pelvic area, Definition of stage D2 prostate cancer - NCI Dictionary of Cancer Metastatic prostate cancer often spreads to the bones. Also called stage IV prostate cancer and stage D1 prostate cancer. Prostate Cancer Treatment - National Cancer Institute Stage IV prostate cancer may also be called stage D1 or stage D2 prostate cancer. Back to Top Back to Top. < Previous Section | Next Section > Prostate Cancer Treatment (PDQ^) Hormonal treatment is the mainstay of therapy for distant metastatic (stage D2) prostate cancer. Cure is rarely, if ever, possible, but striking subjective Intermittent Androgen Deprivation in Patients With Stage D2 Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer (S9346). Questions to Consider Before Participating Learn More Clinical significance of pulmonary metastases in stage D2 prostate Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, Science Links Japan | Primary Treatment for Stage D2 Prostate Primary Treatment for Stage D2 Prostate Cancer: A Randomized Study of Combined Androgen We conclude that in patients with stage D2 prostate cancer, Science Links Japan | Endocrine Therapy of Stage D2 Prostate Abstract;Patients with Stage D2 prostate cancer were treated with surgical or medical (LHRH analog) castration combined with either estrogen, Intermittent Androgen Deprivation in Patients with Stage D2 Intermittent Androgen Deprivation in Patients with Stage D2 Prostate Cancer (H-4233). The purpose of this study is to find out how well patients respond to JAMA -- Abstract: Independent prognostic factors in patients with Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. G. W. Chodak, N. J. Vogelzang, R. J. Caplan, Double-blind, randomized study of primary hormonal treatment of CONCLUSION: As the primary hormonal therapy for stage D2 prostate cancer, DES caused more serious cardiovascular or thromboembolic complications than Estramustine phosphate (estracyt) following androgens in men with in men with refractory stage D2 prostate cancer*. Francesco Boccardo 1, Andrea Decensi 1, Domenico Guarneri 1, Giuseppe Martorana 2, Claudio Giberti 2, Long-term control or possible cure? Treatment of stage D2 prostate D2 prostate cancer under chemotherapy using cisplatin. and estramustine phosphate followed by maximal. androgen blockade. Shinji Urakami v Hiroaki Shiina v Urology : Immunohistochemical study of chromogranin A in Stage D2 To study the clinical and pathologic factors that affect the time to recurrence after hormonal therapy in patients with Stage D2 prostate cancer and to Clinical significance of pulmonary metastases in stage D2 prostate Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic Prostate cancer (PCa) is one of the most common cancers in Western countries |
| d2 prostate cancer |
|
anticholinergics and prostate alpha linolenic acid prostate cancer boron and prostate cancer prostate survival |